InMode Ltd.INMD
Price (close)
$14.19
Market cap
$899.1M
P/E
9.6x
Revenue (FY)
$370.5M
Net income
$93.8M
Dividend yield
—
1-year total return
-4.0%
Net margin
25.3%
Revenue growth
-6.2%
Debt / equity
—
What InMode Ltd. does.
medical treatment solutions. Within the global aesthetics market, our products and solutions are primarily designed to address three energy-based
treatment categories comprised of: (i) face and body contouring; (ii) medical aesthetics; and (iii) women’s wellness. We have developed
and commercialized products utilizing medically accepted RF energy technology, which can penetrate deep into the subdermal fat, allowing
Revenue and profit, by fiscal year.
| Fiscal year | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | $206.1M | $357.6M | $454.3M | $492.0M | $394.8M | $370.5M |
| Net income | $75.0M | $165.0M | $161.5M | $197.9M | $181.3M | $93.8M |
| Free cash flow | $78.8M | $173.9M | $180.0M | $176.1M | $132.0M | $84.3M |
More on INMD.
- InMode Ltd. summary
- InMode Ltd. financial statements
- InMode Ltd. key metrics
- InMode Ltd. health scores and style box
- InMode Ltd. earnings
- InMode Ltd. dividends
- InMode Ltd. valuation
- InMode Ltd. ownership and insiders
- InMode Ltd. peers
Figures from InMode Ltd.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.